• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312

Comprehensive Overview of Methyl 2,4-dibromo-3-fluorobenzoate (CAS No. 1805122-91-1)

Methyl 2,4-dibromo-3-fluorobenzoate (CAS No. 1805122-91-1) is a halogenated aromatic ester with significant applications in pharmaceutical intermediates, agrochemical synthesis, and material science. This compound, characterized by its dibromo and fluoro substituents, exhibits unique reactivity patterns that make it valuable for cross-coupling reactions and functional group transformations. Its molecular formula, C₈H₅Br₂FO₂, highlights its potential as a building block in organic synthesis.

In recent years, the demand for halogenated benzoates like Methyl 2,4-dibromo-3-fluorobenzoate has surged due to their role in developing API intermediates (Active Pharmaceutical Ingredients). Researchers and manufacturers frequently search for "synthetic routes for fluorinated benzoates" or "applications of dibromo-substituted esters," reflecting the compound's relevance in drug discovery. Its stability under mild conditions and compatibility with palladium-catalyzed reactions (e.g., Suzuki-Miyaura coupling) further enhance its utility.

From an environmental perspective, the compound's fluorinated moiety aligns with the growing interest in "green chemistry alternatives" and "sustainable halogenation methods." Studies have explored its biodegradability and potential replacements for more persistent pollutants. Notably, its methyl ester group allows for facile hydrolysis, enabling downstream modifications—a feature often queried in databases like SciFinder and Reaxys.

Analytical techniques such as HPLC, GC-MS, and NMR are routinely employed to characterize Methyl 2,4-dibromo-3-fluorobenzoate. Purity thresholds (>98%) are critical for industrial applications, as impurities can affect catalytic efficiency. Searches for "spectroscopic data of 1805122-91-1" or "CAS 1805122-91-1 suppliers" underscore the need for reliable sourcing and quality control.

Emerging trends also link this compound to advanced material synthesis, particularly in organic electronics and liquid crystals. Its planar aromatic core and halogen atoms facilitate π-stacking interactions, a property leveraged in OLED (Organic Light-Emitting Diode) research. Patent analyses reveal its use in photoresists and dielectric layers, addressing queries like "halogenated aromatics in optoelectronics."

Regulatory compliance remains a key consideration. While not classified as hazardous under major frameworks (e.g., REACH, TSCA), proper handling protocols are recommended due to its brominated structure. Safety Data Sheets (SDS) provide guidance on storage (ambient temperature, inert atmosphere) and PPE (personal protective equipment), topics frequently searched alongside the CAS number.

In summary, Methyl 2,4-dibromo-3-fluorobenzoate (CAS No. 1805122-91-1) bridges multiple disciplines—from medicinal chemistry to materials engineering. Its versatility and evolving applications ensure continued interest, as evidenced by scholarly citations and commercial demand. Future research may focus on optimizing its synthetic pathways or exploring novel derivatives for niche applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)